MARCUS THOMPSON: Open Payments
NPI 1053827576 · GALLATIN, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,347 in 81 payments from 17 companies in 2025. Trend: 2023 $1,384 · 2024 $1,855 · 2025 $1,347
Food & beverage: $1,347
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 21 | $371 |
| ABBVIE INC. | 15 | $163 |
| Astellas Pharma US Inc | 8 | $133 |
| Lilly USA, LLC | 9 | $123 |
| AstraZeneca Pharmaceuticals LP | 6 | $104 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $98 |
| PFIZER INC. | 3 | $70 |
| Amgen Inc. | 4 | $61 |
| Sumitomo Pharma America, Inc. | 2 | $40 |
| Exact Sciences Corporation | 2 | $30 |
Products named: Wegovy, Veozah, CAPLYTA, MOUNJARO, Rybelsus, VRAYLAR, Ozempic, PREVNAR 20.
Industry payments across TN — which companies pay providers there.
